Search Results 501-510 of 18656 for hypothyroidism

1. A Study To Evaluate The Safety And Effectiveness Of Bimagrumab On Improvement In Total Lean Body Mass And Physical Performance Following Surgical Treatment Of Hip Fracture. - Mayo Clinic

   Uncontrolled hypothyroidism requiring a change in the dose of hormone replacement therapy in the last 6 weeks prior to randomization; Uncontrolled ...

2. A Study of Investigational Immunotherapy to Determine the Safety and Effectiveness of Nivolumab and Daratumumab, with or without Pomalidomide and Dexamethasone, in Patients with Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

   Subjects with type I diabetes mellitus, hypothyroidism only requiring hormone replacement, skin disorders (such as vitiligo, psoriasis, or alopecia) not ...

3. A Study to Evaluate ADP-A2M4 with Pembrolizumab to Treat Recurrent or Metastatic Head and Neck Cancer - Mayo Clinic

   Subjects with hypothyroidism, diabetes, adrenal insufficiency or pituitary insufficiency that are stable on replacement therapy are eligible. Subjects with ...

4. Obstetrics and Gynecology - Doctors - Mayo Clinic

   ... Hypothyroidism, Amenorrhea, Uterine anomaly, Septate uterus, Recurrent miscarriage, Balanced translocations, Irregular menstrual cycle, Diminished ovarian ...

5. A Study to Evaluate Tadalafil and Lenalidomide with or without Activated Marrow Infiltrating Lymphocytes (MILs) in High Risk Myeloma - Mayo Clinic

   Hypothyroidism without evidence of Grave's disease or Hashimoto's thyroiditis is permitted. HTLV 1 or 2 positive. Known hypersensitivity to Prevnar or any ...

6. An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer - Mayo Clinic

   Subjects with vitiligo, type I diabetes mellitus, residual hypothyroidism due to autoimmune condition only requiring hormone replacement, psoriasis not ...

7. Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye - Mayo Clinic

   Concurrent uncompensated hypothyroidism or thyroid dysfunction within 7 days before the first dose of study treatment; History of major surgery as follows ...

8. Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05) - Mayo Clinic

   Hypothyroidism/hyperthyroidism;; Type I diabetes;; Hyperglycemia;; Adrenal insufficiency;; Adrenalitis;; Skin hypopigmentation (vitiligo). Has a history of ...

9. A Study to Evaluate the Effectiveness and Safety of rAd-IFN Administered With Celecoxib and Gemcitabine in Patients With Malignant Pleural Mesothelioma - Mayo Clinic

   NOTE: patients with vitiligo, residual hypothyroidism due to auto immune disease only requiring hormone replacement, psoriasis not requiring systemic ...

10. Study to Evaluate Chemoembolization Combined with Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma - Mayo Clinic

    Patients with hypothyroidism (e.g., following Hashimoto syndrome) stable on hormone replacement;; Any chronic skin condition that does not require systemic ...